Optimize Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$450K Buy
+7,208
New +$456K 0.09% 200
2026
Q1
– Sell
-9,140
Closed -$493K – 322
2025
Q4
$493K Buy
9,140
+128
+1% +$6.16K 0.25% 134
2025
Q3
$406K Buy
+9,012
New +$421K 0.21% 207

Other funds holding BMY

Optimize Financial's BMY Position: Q3 2026 in Review

Optimize Financial opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 7,208 shares worth $450K. The stake represents 0.09% of the portfolio and ranks #200 among its holdings. This is a return to the name: Optimize Financial previously reported a position in BMY as recently as Q4 2025.

Optimize Financial first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $493K in Q4 2025. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Optimize Financial held 7,208 shares of Bristol-Myers Squibb worth $450K as of Q3 2026.
  • Bristol-Myers Squibb was a new Optimize Financial position in Q3 2026.
  • Bristol-Myers Squibb made up 0.09% of Optimize Financial's portfolio in Q3 2026, its #200 holding.
  • Optimize Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • Optimize Financial's Bristol-Myers Squibb position peaked at $493K in Q4 2025.
  • 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Optimize Financial's 13F filing for Q3 2026, filed 12 Nov 2026.